Wuwei Heavy-ion Center: Setting New Milestones in Cancer Treatment

Wuwei Heavy-ion Center: Setting New Milestones in Cancer Treatment

Source: Health News

Wuwei Heavy-ion Center (WHIC) at Gansu Wuwei Cancer Hospital—China’s first medical institution utilizing a domestically developed heavy-ion therapy system—has surpassed five years of clinical operation. Over this period, the center has pioneered clinical applications of heavy-ion radiotherapy, treating over 2,000 cancer patients across 50+ malignancies including lung cancer, pancreatic cancer, hepatocellular carcinoma, and glioma, thereby establishing new benchmarks in oncological therapeutics.

​​Driving Innovation to Advance Clinical Capabilities​​

WHIC maintains its trajectory of technological innovation, standing as the world’s sole facility operating dual heavy-ion therapy systems concurrently. It leads globally in daily treatment throughput efficiency via single-fraction protocols. The center has pioneered cutting-edge techniques such as ventilator-controlled precision heavy-ion therapy, bladder-volume-regulated irradiation for bladder cancer, and single-session heavy-ion therapy with surgically implanted spacers isolating tumors from critical organs—all offering new therapeutic hope for complex cases. Its proprietary 360-degree rotatable-elevating ion therapy chair enhances targeting accuracy. WHIC has successfully treated multiple cardiac tumor patients and innovatively integrated comprehensive, full life-cycle mental and physical health management with heavy-ion therapy. Partnerships with domestic insurers facilitate reimbursement pathways, expanding access to this globally leading technology.

​​Accelerating Standardization Through Research​​

WHIC has launched eight clinical research projects on heavy-ion therapy, providing research funding to expert teams and enabling patient participation. These studies expedited national standardization for heavy-ion treatment of complex cancers, transforming clinical techniques for multiple tumor types into evidence-based guidelines and standards. This contributes framework solutions for standardizing and refining heavy-ion medical technology both in China and internationally.

​​Leading Industry Advancement via Knowledge Integration​​

Anchored in its mission to "Forge Industry Standards and Disseminate Cutting-Edge Expertise," WHIC has compiled essential publications including: Heavy-Ion Therapy Radiation Safety Management and Equipment Operation Guidelines, Carbon-Ion Radiotherapy Standard Operating Procedures, the Precision Carbon-Ion Radiotherapy for Cancer Series (Physics, Technical, and Physician Volumes), TCM Constitution Classification and Health Management, Practical Handbook of Cancer Hospital Management Systems, Comprehensive Life-Cycle Rehabilitation Management for Cancer Patients, and Multidisciplinary Perspectives on Carbon-Ion Cancer Therapy. These works propel industry innovation through knowledge sharing, empowering medical professionals to scientifically adopt heavy-ion technology and benefit broader patient populations.

​​Strengthening Expertise Through Global Talent Acquisition​​

WHIC advances the Heavy-Ion Therapy Alliance and 50 expert workstations while deepening collaborations with world-leading medical institutions. This facilitates the integration of frontier diagnostics, therapeutic concepts, and innovative technologies, sustaining the center’s high-quality development. It retains eminent international and domestic experts in radiation medicine and proton/heavy-ion technology. Recent additions of specialists in relevant fields have further enriched WHIC’s cross-disciplinary expert智库, integrating Eastern and Western insights across the heavy-ion treatment continuum and reinforcing its talent ecosystem.

​​Executive Perspective​​

WHIC leadership states: "Five years of dedicated development have propelled our transition from global follower to pioneer in the anti-cancer arena. Our novel technologies are reshaping oncology paradigms and demonstrating China’s substantial strength in medical innovation. Moving forward, we will drive the intelligent, precise, and standardized evolution of heavy-ion therapy, establish a world-class research hub, refine full life-cycle health services, promote Chinese standards globally, and energize the global health community."